Impact of a mindfulness training on emotional intelligence, resilience, work engagement, perceived stress, and wellbeing

ISRCTN ISRCTN48912721
DOI https://doi.org/10.1186/ISRCTN48912721
Secondary identifying numbers 3462
Submission date
02/11/2020
Registration date
17/11/2020
Last edited
06/04/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Occupational (work) pressure is recognized as a major source of stress for adults. Long-term stress can contribute to adverse health habits and is a known risk factor in many disease states, increases in absenteeism and a reduction in productivity in the workplace. Because of the prevalence and cost of this problem, an intervention designed to help the stress of staff, which will ultimately lead to the development of emotional well-being, could be beneficial to both employees and employers. Traditionally delivered Mindfulness-Based Stress Reduction (MBSR) programs, which teach core mindfulness concepts, have been well researched with many beneficial healing effects. A potential deterrent to the utilization of a traditionally delivered MBSR program in a workplace setting is the expected participant time commitment. Additional obstacles are a stigma on stress and the absence of a clear link between MBSR content and the workplace. To address these needs, we have created Mindfulness-Based Mental Agility.
The objective of this study is to determine whether Mindfulness-Based Mental Agility training, created for the workplace, is efficacious in decreasing stress of employee while enhancing emotional intelligence, work engagement, resiliency, well-being and mindfulness.

Who can participate?
Participants will be recruited from the WHO EURO and UN City personnel.

What does the study involve?
All participants will complete module 1 of the training (6 weeks). If they wish to continue, they will also complete module 2 (4 weeks).
The intervention is standardized and consists of training built on 2 modules which are delivered online for 1 - 2 hours each week. In order to measure the impact of the full training, follow-up measures for the intervention will be obtained 1 and 6 months after Module 2. In order to measure the impact of Module 1 alone, follow-up measures will be obtained 1 and 6 months after Module 1 if participants don’t register for Module 2 of the training.

What are the possible benefits and risks of participating?
Participants will learn new skills and have the benefits related to the mindfulness-based practice. In addition, participants will receive a personal summary of the evaluations completed during the questionnaires.
Their participation is likely to help us find the impact of the training. Based on these results, the MBMA will be implemented at a larger scale, be offered to a larger population of employees, and integrated into a long-term strategy of Staff Development and Learning.
The researchers do not anticipate any risks from taking part.

Where is the study run from?
World Health Organization, Regional Office for Europe (Denmark)

When is the study starting and how long is it expected to run for?
September 2020 to December 2021

Who is funding the study?
World Health Organization (Switzerland)

Who is the main contact?
Dr Pierre-Olivier Dondoglio
dondogliopi@who.int

Contact information

Dr Pierre-Olivier Dondoglio
Scientific

World Health Organization, Regional Office for Europe
UN City
Marmorvej 51
Copenhagen
2100
Denmark

ORCiD logoORCID ID 0000-0002-7198-4882
Phone + 45 40 22 14 05
Email dondogliopi@who.int
Dr Pierre-Olivier Dondoglio
Public

World Health Organization, Regional Office for Europe
UN City
Marmorvej 51
Copenhagen
2100
Denmark

ORCiD logoORCID ID 0000-0002-7198-4882
Phone + 45 40 22 14 05
Email dondogliopi@who.int

Study information

Study designInterventional cohort study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Other
Study typeQuality of life
Participant information sheet No participant information sheet available
Scientific titleMindfulness-based mental agility: impact of a virtual face to face workplace intervention
Study acronymMBMA
Study objectivesThe post-intervention evaluations will show a significant decrease in perceived stress as well as increased mindfulness, resiliency, wellbeing, emotional intelligence and work engagement.
Ethics approval(s)Approved 02/11/2020, World Health Organization Ethic Review Committee (Avenue Appia 20, 1211 Geneva, Switzerland; +41 22 791 1479; guraiibm@who.int), ref: 3462
Health condition(s) or problem(s) studiedEmotional intelligence, resiliency, work engagement, perceived stress, mindfulness, wellbeing.
InterventionThe intervention consists of a mindfulness-based approach delivered via live online meetings. This program is significantly modified from traditional Mindfulness-Based Stress Reduction to create a clear link between mindfulness and the 4 domains of Emotional Intelligence. Module 1 is composed of 1 live online training per week for 6 weeks for a total of 8 hours. Module 2 is composed of 1 live online training per week for 4 weeks for a total of 8 hours. The teacher is an MD familiar with Mindfulness-Based training and follows internationally recognized Good Practice Guidelines for Mindfulness-based Approaches.
Intervention typeBehavioural
Primary outcome measureMeasured at baseline and post-intervention (at 1 month and 6 months):
1. Emotional intelligence (S-PEC)
2. Resiliency (BRS)
3. Work engagement (SMVS)
4. Perceived stress (PSS-10 and a single-item measure of stress symptoms)
5. Mindfulness (MAAS)
6. Well-being (WHO-5)
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date01/09/2020
Completion date31/12/2021

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants135
Key inclusion criteriaModule 1
1. Participation in the information meeting
2. Ensuring commitment towards personal practice
3. Commitment to complete the questionnaires
4. Working for WHO (any office of EURO) or a UN agency based in UN City Copenhagen
5. Greater than 18 years of age

Module 2
1. Completion of Module 1 (minimum 93%)
2. Individual evaluation of medical pre-condition (questionnaire -Annex2- plus individual consultation if one risk factor is identified)
3. Ensuring commitment towards personal practice
4. Commitment to complete the questionnaires for Module 2
Key exclusion criteriaThere are no exclusion criteria for Module 1

Module 2
1. Medical pre-condition which is a contraindication to the practices taught during Module 2 (e.g. Post-Traumatic Stress Disorder, acute depression).

Participants will be excluded from the study if they end their participation during the training
Date of first enrolment03/11/2020
Date of final enrolment25/04/2021

Locations

Countries of recruitment

  • Denmark

Study participating centre

World Health Organization, Regional Office for Europe
UN City
Marmorvej 51
Copenhagen
2100
Denmark

Sponsor information

World Health Organization Regional Office for Europe
Government

UN City
Marmorvej 51
Copenhagen
2100
Denmark

Phone + 45 40 22 14 05
Email dondogliopi@who.int
Website http://www.euro.who.int/en
ROR logo "ROR" https://ror.org/01rz37c55

Funders

Funder type

Research organisation

World Health Organization
Private sector organisation / International organizations
Alternative name(s)
منظمة الصحة العالمية, 世界卫生组织, Всемирная организация здравоохранения, Organisation mondiale de la Santé, Organización Mundial de la Salud, WHO, 世卫组织, ВОЗ, OMS
Location
Switzerland

Results and Publications

Intention to publish date30/11/2022
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
Publication and dissemination planEach participant will receive a personal analysis of the evaluation of their different score collected during the research. A personal consultation with the psychologist will be offered to discuss individual evaluations.

Results will also be shared with EURO Learning Committee, EURO Staff Development and Learning, and Global Learning and Development Committee.

The intention is to also publish the results in a peer-reviewed journal. The principal investigator will take the lead in the publication with all researchers involved based on their role in design of the study, field work and writing the manuscript. Potential co-authors include but limited with the members of the Team. This investigators will also make all possible to ensure that each participant becomes familiar with the results of the study within 3 months from the date of the first publication on the study.
IPD sharing planAll data generated or analysed during this study will be included in the subsequent results publication.

Editorial Notes

06/04/2021: The recruitment end date has been changed from 15/03/2021 to 25/04/2021.
20/11/2020: The ethics approval was added.
13/11/2020: Trial’s existence confirmed by WHO Ethics Review Committee